NEW YORK (GenomeWeb News) — PerkinElmer’s bid to buy ViaCell has passed the Hart-Scott-Rodino antitrust waiting period, which expired yesterday.
 
Separately today, PerkinElmer declared a $.07 quarterly dividend payable on Feb. 8, 2008, to all stockholders of record at the end of Jan. 18, 2008.
 
The company is scheduled to release its quarterly earnings after the close of trading today.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.